AlphaCrest Capital Management LLC lowered its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 72.1% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 36,746 shares of the real estate investment trust’s stock after selling 94,827 shares during the period. AlphaCrest Capital Management LLC’s holdings in Sabra Health Care REIT were worth $482,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. EverSource Wealth Advisors LLC purchased a new position in shares of Sabra Health Care REIT during the 3rd quarter valued at about $29,000. Point72 Hong Kong Ltd purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter valued at about $31,000. Lazard Asset Management LLC purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter valued at about $38,000. Worth Asset Management LLC purchased a new position in shares of Sabra Health Care REIT during the 1st quarter valued at about $44,000. Finally, SeaCrest Wealth Management LLC purchased a new position in shares of Sabra Health Care REIT during the 2nd quarter valued at about $58,000. Hedge funds and other institutional investors own 87.20% of the company’s stock.
Sabra Health Care REIT Trading Down 2.6 %
SBRA stock opened at $11.57 on Friday. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.82. Sabra Health Care REIT, Inc. has a 12-month low of $11.44 and a 12-month high of $16.60. The stock has a market cap of $2.67 billion, a price-to-earnings ratio of -34.03 and a beta of 1.30. The business’s 50-day moving average is $12.86 and its 200 day moving average is $13.12.
Sabra Health Care REIT Announces Dividend
Wall Street Analyst Weigh In
SBRA has been the subject of a number of recent research reports. Bank of America lowered Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $15.00 to $13.00 in a research note on Monday, November 14th. JMP Securities cut Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a research report on Tuesday, December 13th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $14.50.
Sabra Health Care REIT Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Read More
- Get a free copy of the StockNews.com research report on Sabra Health Care REIT (SBRA)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating).
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.